информационный портал
для специалистов

Физико-химическая биология

Клиническая медицина

Профилактическая медицина

Медико-биологические науки


Фундаментальные исследования

Организация здравохраниения

История медицины и биологии

Последние публикации

Поиск публикаций


Архив :  2000 г.  2001 г.  2002 г. 
               2003 г.  2004 г.  2005 г. 
               2006 г.  2007 г.  2008 г. 
               2009 г.  2010 г.  2011 г. 
               2012 г.  2013 г.  2014 г. 
               2015 г.  2016 г.  2017 г. 
               2018 г.  2019 г. 

Редакционная информация:
        Опубликовать статью
        Наша статистика

Главный редактор

Заместители главного редактора

Члены редколлегии
Специализированные редколлегии

Федеральное государственное бюджетное учреждение науки
"Институт токсикологии Федерального медико-биологического агентства"

Институт теоретической и экспериментальной биофизики Российской академии наук.


Адрес редакции и реквизиты

199406, Санкт-Петербург, ул.Гаванская, д. 49, корп.2

ISSN 1999-6314

Российская поисковая система

Vol. 16, Art. 104 (pp. 1184-1194)    |    2015       

Impact of some cationic channels blockers on the activation of rat papillary muscles and aorta rings by ammonium ions.
Averin A.S.1, Nakipova O.V.1, Andreeva L.A.1, Averina I.V.1, Sergeev А.I.1, Grishina E.V.2, Galimova M.H.2, Nenov N.M., Dynnik V.V.2

1Federal State Budget Organization of Science ,Institute of Cell Biophysics RAS, 142290, Pushchino, Russia, Institutskaya 3
2Federal State Budget Organization of Science, Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, 142290, Pushchino, Russia, Institutskaya 3

Brief summary

Abstract Main purpose of this work is to investigate the effects of coenzyme NAD+ and of some cationic channels or receptors blockers on the activation of rat myocardial papillary muscle strips (PMS) and aorta rings (AR) by ammonium ions. Isometric contractions force F1 of electrically stimulated PMS (0,03 to 0,3Hz ) and the force F2 of periodic contractions of AR, precontracted by phenylephrine (PE) or serotonin (5-HT), were recorded. It was shown that NH4Cl (1-5 mM) may result in the increase of force F1 of PMS and of force F2 of AR, both by 20-30%. In the presence of NAD+ (1−3 mM), registered values of F1 and F2 were reduced by 50-60%. The effect of NAD+ was completely eliminated, after preincubation of PMS with P2- purinoreceptors blockers (Reactive Blue). In AR the recovery of F2 in the presence of Reactive Blue was not complete (40−50% of control F0). Application of NH4Cl (3−5mM) to PMS, pretreated with NAD+, eliminated hyperpolarizing effect of NAD+ , by causing an increase of force F1 to 120−130% of control force F0. In AR, the additions of NH4Cl (1−10 mM) were characterized by biphasic dose-dependent effects, in which initial decline in force F2 were substituted by the overshoots with final plateau phase F2 values lower than F0. NH4Cl (1-5 mM) suppresses Ca++ -currents of potential- dependent Ca++ L-type channels in isolated cardiomyocytes. Observed effects of NH4Cl on PMS disappear in the presence of ZD 7288 (20−30 mkM) − the blocker of hyperpolarization−activated cyclic nucleotide dependent cationic (HCN) -channels, or after the application of Iberiotoxin (6 nM), known blocker of the receptors of Ca++-activated high conductivity potassium channels (BKCa). The effects, produced by both blockers in AR, were less pronounced. Taken together, all these results may indicate that in electrically excitable myocardial and smooth muscle (vascular) cells, like in neural cells, ammonia causes universal activation (depolarization), implicating the group of cationic channels (HCN, BKCa, SKCa, etc.).

Key words

Keywords: myocardium, aorta, ammonium ion, coenzyme NAD+, cationic HCN channels, BKCa- channels, hyperammonemia.

(The article in PDF format. For preview need Adobe Acrobat Reader)

Open article in new window

Reference list

1. Bjerring, P.N.; Eefsen, M.; Hansen, B.A.; Larsen, F.S. The brain in acute liver failure. A tortuous path from hyperammonemia to cerebral edema. Metab Brain Dis. 2009 Mar;24(1):5-14.

2. Perazzo, J.C.; Tallis, S.; Delfante, A.; Souto, P.A.; Lemberg, A.; Eizayaga, F.X.; Romay, S. Hepatic encephalopathy: An approach to its multiple pathophysiological features. World J Hepatol, 2012, 4(3), 50-65.

3. Grishina, E.V.; Kravtchenko, I.N.; Lobanov, A.V.; Sergeev, A.I.; Sadovnikova, E.S.; Dynnik, V.V. Selection of complex commpositions of protectors of hyperammonemia and acute hepatic encephalopathy. Medline.ru, 2015, 16 (art.96), 1077-1098.

4. Häussinger D., Görg B. Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity// Curr. Opin. Clin. Nutr. Metab. Care, 2010, vol.13, pp. 87- 92.

5. Jayakumar, A.R.; Bethea, J.R.; Tong, X.Y.; Gomez, J.; Norenberg, M.D. NF-κB in the mechanism of brain edema in acute liver failure: studies in transgenic mice. Neurobiol Dis, 2011, 41(2), 498-507.

4. Hahn, M.; Massen, O.; Nencki, M.; Pawlow, J.; Die Ecksche Fistel zwi der unteren Hohlvene und der Pfortader und ihre Folgen fur den Organismus; Arch. Exp.Pathol. Pharmakol, 1893, 32, 161-210.

5. Nencki, M.; Zaleski, J. Ueber die Bestimmung des Ammoniaks in Thierischen Fluessigkeiten und Geweben. Arch. Exp. Pathol. Pharmakol. 1895, 36, 385-396.

6. Nencki, M.; Pawlow, J.P.; Zaleski, J. Ueber den Ammoniakgehalt des Bluttes und der Organe. Die Harnstoffbildung bei den Saugetieren. Arch. Exp. Pathol. Pharmakol, 1896, 37, 26-51.

7. McDermott, W.V. Jr. The role of ammonia intoxication in hepatic coma. Bull. N. Y. Acad. Med, 1958, 34(6), 357-65.

8. Sherlock, S. Hepatic coma. Gastroenterology. Official publication of the American Gastroenterological Association, 1961, 7, 1-8.

9. Zuidema, G.D.; Kirsh, M.M.; Gaisford, W.D. Hepatic encephalopathy. Major Probl Clin Surg, 1964, 1, 102-126.

10. Rose, C.F. Ammonia-lowering strategies for the treatment of hepatic encephalopathy. Clin Pharmacol Ther, 2012, 92(3), 321-31.

11. Rama Rao, K.V.; Norenberg, M.D. Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited. Neurochem Res, 2014, 39(3), 593-8.

12. Bosoi, C.R.; Zwingmann, C.; Marin, H.; Parent-Robitaille, C.; Huynh, J.; Tremblay, M.; Rose, C.F. Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. J Hepatol, 2014, 60(3), 554-60.

13. Cauli, O.; González-Usano, A.; Cabrera-Pastor, A.; Gimenez-Garzó, C.; López-Larrubia, P.; Ruiz-Sauri, A.; Hernández-Rabaza, V.; Duszczyk, M.; Malek, M.; Lazarewicz, J.W.; Carratalá, A.; Urios, A.; Miguel, A.; Torregrosa, I.; Carda, C.; Montoliu, C.; Felipo, V. Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain. Neuromolecular Med, 2014, 16(2), 360-75.

14. Dynnik, V.V.; Kononov, A.V.; Sergeev, A.I.; Teplov, I.Y.; Zinchenko, V.P. To break or to brake neuronal network accelerated by ammonium ions? PLoS ONE, 2015, 10(7), e0134145.

15. Kononov, A.V.; Galimova, M.H.; Dynnik, V.V. Impact of Methyl L-Methionine, coenzyme NAD+, certain blockers of cation channels and kinase G on hyperactivation of neuronal networks by ammonium ions. Medline.ru, 2015, 16 (95), 1062-1076.

16. Nakipova O.V., Zakharova N.M., Andreeva L.A., Chumaeva N.N Averin AS. Kosarskii L.S., Anufriev A.I. Lewinski DV, Kockskamper J, Pieske B. The seasonal peculiarities of force-frequency relationships in active ground squirrel Spermophilus undulatus ventricle. J. Cryobiology, 2007, v. 55, N 3, pp. 173 - 181.

17. Andreeva, L.A.; Grishina, E.V.; Sergeev, A.I.; Lobanov, A.V.; Slastcheva, G.A.; Rykov, V.A.; Temyakov, A.V.; Dynnik, V.V. ?EMERGENCE OF ACETYLCHOLINE RESISTANCE AND LOSS OF RHYTHMIC ACTIVITY ASSOCIATED WITH THE DEVELOPMENT OF HYPERTENSION, OBESITY, AND TYPE 2 DIABETES?, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. 2016, 10(3),199-206.

18. Gryshin K.S., Nenov M.N., Dinnik V.V., Semyshina S.G., Pahomova I.A., Myrashev A.N., Kokoz U.M.?Rol NO-cGMP kaskada v regylyacii Sa2+ toka L-tipa v izolirovannih kardiomiocitah.// Biologicheskie membrani. t.25, N5, s. 377-387,2008

19. Moreschi I.,?Bruzzone S.,?Nicholas R.A et al. Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes. //J. Biol. Chem.,?2006,?vol. 281(42), pp. 31419-29.

20. Kilfoil P.J., Tipparaju S.M., Barski O.A. et al. Regulation of ion channels by pyridine nucleotides. //Circ. Res., 2013, vol. 112 (4), pp.721-741.

Свидетельство о регистрации сетевого электронного научного издания N 077 от 29.11.2006
Журнал основан 16 ноября 2000г.
Выдано Министерством РФ по делам печати, телерадиовещания и средств массовых коммуникаций
(c) Перепечатка материалов сайта Medline.Ru возможна только с письменного разрешения редакции

Размещение рекламы

Rambler's Top100